Nateglinide
Nateglinide is a prescription medication used to help control blood sugar levels in adults with type 2 diabetes. It works by stimulating the pancreas to release more insulin, especially after meals. Available as 60 mg or 120 mg oral tablets, it's a generic version manufactured by Strides Pharma Science Limited. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Nateglinide is a prescription medication used to help control blood sugar levels in adults with type 2 diabetes. It works by stimulating the pancreas to release more insulin, especially after meals. Available as 60 mg or 120 mg oral tablets, it's a generic version manufactured by Strides Pharma Science Limited. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Nateglinide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Nateglinide — ANDA 205544 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205544"
}
]
|
| identifier | ANDA205544 |
| issued | 2016-09-16 |
| keyword |
[
"fda",
"medications",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Nateglinide |
